4//SEC Filing
Brennan Kevin M. 4
Accession 0001415889-24-012152
CIK 0001840233other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:10 PM ET
Size
5.5 KB
Accession
0001415889-24-012152
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Award
Stock Option (right to buy)
2024-05-01+20,000→ 20,000 totalExercise: $1.08Exp: 2034-04-30→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option award was granted on May 1, 2024 and shall vest on June 1, 2024 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until May 1, 2028.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001971303
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:10 PM ET
- Size
- 5.5 KB